Puma Biotechnology Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Puma Biotechnology

Access the complete profile.

Puma Biotechnology Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	10880 Wilshire Blvd #02150 Los Angeles, CA 90024

Puma Biotechnology's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Puma Biotechnology's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Puma Biotechnology is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Puma Biotechnology is a publicly traded company on NMS using the ticker symbol PBYI. Detailed information on company financials and operating reports can be found here: NMS: PBYI

Puma Biotechnology Annual Revenue and Growth Rate

Puma Biotechnology	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Puma Biotechnology's revenues are gauged from an analysis of company filings.

Investor Activity

Puma Biotechnology has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 1, 2011	139	100%	$5 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Puma Biotechnology is developing and marketing. Puma Biotechnology doesn't have any recent trademark applications, indicating Puma Biotechnology is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PUMAPATIENTLYNX pharmaceutical products for the prevention and treatment of cancer	07/11/2017
PUMA BIOTECHNOLOGY Pharmaceutical products for the prevention and treatment of cancer	06/30/2015
NERLYNX Pharmaceutical products for the prevention and treatment of cancer	06/30/2015

See all trademarks and details in the Full Report.

Market Share of Puma Biotechnology's Largest Competitors

A competitive analysis shows these companies are in the same general field as Puma Biotechnology, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Puma Biotechnology. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOVASIGNAL	Los Angeles, CA	100
PUMA BIOTECHNOLOGY	Los Angeles, CA	84
SILVUS TECHNOLOGIES	Los Angeles, CA	82
ELLISON INSTITUTE	Los Angeles, CA	78
SOMATIS SENSOR SOLUTIONS	Los Angeles, CA	69
C3J THERAPEUTICS	Los Angeles, CA	55

Future Competition: Puma Biotechnology's Fastest Growing Competitors

These companies are in the same general field as Puma Biotechnology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)